Dr. Srivastava is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1801 W Taylor St
Suite 3D
Chicago, IL 60612Phone+1 312-413-5569
Education & Training
Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2013 - 2017
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2010 - 2013
Saint Louis University School of MedicineClass of 2010
Certifications & Licensure
IL State Medical License 2017 - 2026
MA State Medical License 2014 - 2017
TX State Medical License 2012 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- Circulating Protein and Metabolite Correlates of Histologically Confirmed Diabetic Kidney Disease.Carolina Lopez-Silva, Aditya Surapaneni, Insa M Schmidt, Dhairya Upadhyay, Anand Srivastava
Kidney Medicine. 2024-12-01 - Past, present, and future biomarkers of kidney function and injury: The relationship with antibiotics.Jack Chang, Gwendolyn M Pais, Erin F Barreto, Bryce Young, Haley Scott
International Journal of Antimicrobial Agents. 2024-11-01 - Membrane lateral organization from potential energy disconnectivity graph.Sahithya Sridharan Iyer, Anand Srivastava
Biophysical Chemistry. 2024-10-01
Press Mentions
GIOSTAR Announces FDA Clearance of the IND for Starting PHASE-2 Clinical Trial for Developing Specific Stem Cell Therapy for Type II DiabetesNovember 13th, 2024- King George’s Medical University Patient Goes Home After Challenging TransplantJuly 14th, 2021
- Introducing Memory in Coarse-Grained Molecular SimulationsMay 13th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
